EE434 Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer

Abstract

Authors

D Abushanab A Gulied A Hamad P Abdul Rouf M Al Hail W Elkassem M El Hajj D Al-Badriyeh

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×